DGX Filing
4Filing Date: Jul 27, 2026

QUEST DIAGNOSTICS INC (DGX) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001022079-26-000083open_in_new
Total Value$9.5K
Trades1
Insiders1

Transaction Details

Plewman Patrick
SVP for Diagnostic Services·Direct
· Acquire
Common Stock
Shares+46
Price$206.81
Total Value$9.5K
Shares Owned After15.29K
Transaction DateJul 22, 2026
Footnotes ▸

Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Post-Transaction Holdings

Plewman Patrick
SecuritySharesChange
Common Stock15.29K+46 (0.30%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-22 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: QUEST DIAGNOSTICS INC (DGX) CIK: 0001022079 --- Reporting Owner --- Name: Plewman Patrick CIK: 0001497368 Role: Officer (SVP for Diagnostic Services) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-22 | Code: L Shares: +46 | Price: $206.81 Total Value: $9,513.12 Shares Owned After: 15,293 | Ownership: D (Direct) Footnotes: [F1] Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. --- Footnotes (Complete Index) --- F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. --- Signature --- /s/ Sean D. Mersten, Attorney in Fact for Patrick Plewman (2026-07-27)

keid AI analysis is for reference only and does not constitute investment advice.